Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.55 |
| ▸ | TP53 | P04637 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | BACE1 | P56817 | 4/20 | 0.50 |
| ▸ | APP | P05067 | 1/20 | 0.50 |
| ▸ | TYR | P14679 | 1/20 | 0.49 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.46 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7862290 | 0.86 | CYP1A1 (0.55) | MAPTTP53KDM4EMAPK1ALDH1A1 | |
| SCHEMBL13039518 | 0.86 | CYP1A1 (0.55) | MAPTTP53KDM4EMAPK1ALDH1A1 | |
| SCHEMBL28857462 | 0.84 | MAPT (0.59) | MAPTTP53KDM4EMAPK1ALDH1A1 | |
| SCHEMBL9859462 | 0.82 | TYR (0.55) | TP53ALDH1A1CYP3A4HPGDCA1 | |
| SCHEMBL9742941 | 0.81 | TTR (0.50) | MAPTTP53KDM4EMAPK1ALDH1A1 | |
| SCHEMBL9742937 | 0.81 | TTR (0.50) | MAPTTP53KDM4EMAPK1ALDH1A1 | |
| SCHEMBL28870795 | 0.80 | XDH (0.53) | MAPTTP53KDM4EMAPK1ALDH1A1 | |
| SCHEMBL28870792 | 0.80 | XDH (0.53) | MAPTTP53KDM4EMAPK1ALDH1A1 | |
| SCHEMBL31501089 | 0.79 | BACE1 (0.59) | MAPTTP53KDM4EMAPK1ALDH1A1 | |
| SCHEMBL28560182 | 0.78 | HMGCR (0.48) | KDM4ECYP3A4CA1CA2ABCG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9080109-B2 | Methods for deoxygenating biomass-derived pyrolysis oil | UOP LLC (US) | 2015-07-14 | — | — | US | claimed |
| US-20130158329-A1 | METHODS FOR DEOXYGENATING BIOMASS-DERIVED PYROLYSIS OIL | UOP LLC (US) | 2013-06-20 | — | — | US | claimed |
| US-20120157370-A1 | WASHING PERFORMANCE USING RADICAL TRAPS | HENKEL AG & CO. KGAA (DE) | 2012-06-21 | — | — | US | claimed |
| US-9163181-B2 | Methods and apparatuses for deoxygenating biomass-derived pyrolysis oil | UOP LLC (US) | 2015-10-20 | — | — | US | disclosed |
| US-9080109-B2 | Methods for deoxygenating biomass-derived pyrolysis oil | UOP LLC (US) | 2015-07-14 | — | — | US | disclosed |
| US-20130345487-A1 | METHODS AND APPARATUSES FOR DEOXYGENATING BIOMASS-DERIVED PYROLYSIS OIL | UOP LLC (US) | 2013-12-26 | — | — | US | disclosed |
| US-20130158329-A1 | METHODS FOR DEOXYGENATING BIOMASS-DERIVED PYROLYSIS OIL | UOP LLC (US) | 2013-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120157370-A1 | WASHING PERFORMANCE USING RADICAL TRAPS | MPO, DNASE1, PLD4 | MAPT 2017/4885TP53 2193/4885KDM4E 677/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.